NCT03963544 - Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST) | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 31, 1990

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Gastro Intestinal Stromal Tumor

Interventions

DRUG

oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations

oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR

Trial Locations (1)

RECRUITING

Institut Bergonié, Comprehensive Cancer Center, Bordeaux